Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Estrogen receptor-α (ERα)-negative breast cancer is clinically aggressive and normally does not respond to conventional estrogen target-directed therapies. The soybean isoflavone, genistein (GE), has been shown to prevent and inhibit breast cancer and recent studies have suggested that GE can enhance the anticancer capacity of an estrogen antagonist, tamoxifen (TAM), especially in ERα-positive breast cancer cells. However, the role of GE in ERα-negative breast cancer remains unknown. METHODS: We have evaluated the in vitro and in vivo epigenetic effects of GE on ERα reactivation by using MTT assay, real-time reverse transcription-polymerase chain reaction (RT-PCR) assay, western-blot assay, immunoprecipitation (ChIP) assay, immunohistochemistry and epigenetic enzymatic activity analysis. Preclinical mouse models including xenograft and spontaneous breast cancer mouse models were used to test the efficacy of GE in vivo. RESULTS: We found that GE can reactivate ERα expression and this effect was synergistically enhanced when combined with a histone deacetylase (HDAC) inhibitor, trichostatin A (TSA), in ERα-negative MDA-MB-231 breast cancer cells. GE treatment also re-sensitized ERα-dependent cellular responses to activator 17β-estradiol (E2) and antagonist TAM. Further studies revealed that GE can lead to remodeling of the chromatin structure in the ERα promoter thereby contributing to ERα reactivation. Consistently, dietary GE significantly prevented cancer development and reduced the growth of ERα-negative mouse breast tumors. Dietary GE further enhanced TAM-induced anti-cancer efficacy due at least in part to epigenetic ERα reactivation. CONCLUSIONS: Our studies suggest that soybean genistein can epigenetically restore ERα expression, which in turn increases TAM-dependent anti-estrogen therapeutic sensitivity in vitro and in vivo. The results from our studies reveal a novel therapeutic combination approach using bioactive soybean product and anti-hormone therapy in refractory ERα-negative breast cancer which will provide more effective options in breast cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261 · cited 3×
“TAM has also been shown to have potential benefit for the prevention of breast cancer among women at high risk of breast cancer [1].”
BackgroundChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200 · cited 1×
“We initiated our in vivo studies by applying single GE treatments rather than GE/TSA combination in mice diet due to potential toxicity of TSA in previous clinical studies [43,44].”
MethodSoy intake and cancer risk: A review of the in vitro and in vivo data
Messina, M. J., Persky, V., Setchell, K. D. R., & Barnes, S. (1994) · Nutrition and Cancer · doi:10.1080/01635589409514310 · Cited by 1,315 · cited 1×
“Genistein (GE) exerts its anti-cancer properties through various mechanisms such as anti-oxidation, induction of apoptosis and differentiation as well as inhibition of angiogenesis and proliferation [21-24].”
BackgroundEstrogen receptor interaction with estrogen response elements
Klinge, C. M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.14.2905 · Cited by 1,081 · cited 3×
“However, aberrant activation of estrogen-ER signaling renders unlimited and uncontrolled cell proliferation which occurs in most breast tumors [5-7].”
BackgroundDolinoy, D. C., Weidman, J. R., Waterland, R. A., & Jirtle, R. L. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8700 · Cited by 934 · cited 1×
“00417; Harlan Teklad) [33].”
Genistein, a dietary-derived inhibitor of in vitro angiogenesis.
Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., & Schweigerer, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2690 · Cited by 766 · cited 1×
“Genistein (GE) exerts its anti-cancer properties through various mechanisms such as anti-oxidation, induction of apoptosis and differentiation as well as inhibition of angiogenesis and proliferation [21-24].”
BackgroundConnections and Regulation of the Human Estrogen Receptor
McDonnell, D. P., & Norris, J. D. (2002) · Science · doi:10.1126/science.1071884 · Cited by 579 · cited 3×
“to E2 and TAM In the presence of ER, a series of ER-dependent cellular responsiveness is stimulated including cellular proliferation and downstream ER-response gene expression by binding ER with hormone signals such as 17β-estradiol (E2) [4,5].”
BackgroundOttaviano, Y. L., Issa, J. J., Parl, F. F., Smith, H. S., Baylin, S. B., & Davidson, N. E. (1994) · PubMed · Cited by 559
Yang, X., Phillips, D. L., Ferguson, A. T., Nelson, W. G., Herman, J. G., & Davidson, N. E. (2001) · PubMed · Cited by 500
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
Clarke, R., Liu, M. C., Bouker, K. B., Gu, Z., Lee, R. Y., Zhu, Y., Skaar, T. C., Gomez, B., O'Brien, K., Wang, Y., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206937 · Cited by 478 · cited 3×
“ER-positive breast cancers respond to hormonal therapy; however, at least 20% of breast cancer cells that lack of ER expression are more aggressive and have a poor prognosis [3].”
BackgroundOkura, A., Arakawa, H., Oka, H., Yoshinari, T., & Monden, Y. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80030-5 · Cited by 437 · cited 1×
“Genistein (GE) exerts its anti-cancer properties through various mechanisms such as anti-oxidation, induction of apoptosis and differentiation as well as inhibition of angiogenesis and proliferation [21-24].”
BackgroundFang, M. Z., Chen, D., Sun, Y., Jin, Z., Christman, J. K., & Yang, C. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0406 · Cited by 410 · cited 1×
“One potential mechanism that has recently received considerable attention is that GE may regulate gene transcription by modulating epigenetic events [25-27].”
BackgroundEffect of Genistein on In Vitro and In Vivo Models of Cancer
Barnes, S. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.3_suppl.777s · Cited by 364 · cited 1×
“Soybean product is a rich source of genistein isoflavone, which is believed to be a potent botanical chemopreventive compound against various types of cancers, including breast cancer [20].”
BackgroundDong, J.-Y., & Qin, L.-Q. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1270-8 · Cited by 359 · cited 1×
“Asian women who consume soybean food as their primary daily diet show low incidence of breast cancer suggesting protective effects of this diet [18,19,38].”
BackgroundEstrogen Receptor Alpha in Human Breast Cancer: Occurrence and Significance
Ali, S., & Coombes, R. C. (2000) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009594727358 · Cited by 329 · cited 1×
“However, aberrant activation of estrogen-ER signaling renders unlimited and uncontrolled cell proliferation which occurs in most breast tumors [5-7].”
BackgroundAddressing the Soy and Breast Cancer Relationship: Review, Commentary, and Workshop Proceedings
Messina, M., McCaskill-Stevens, W., & Lampe, J. W. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj356 · Cited by 308 · cited 2×
“Asian women who consume soybean food as their primary daily diet show low incidence of breast cancer suggesting protective effects of this diet [18,19,38].”
BackgroundMentor-Marcel, R. A., Lamartiniere, C. A., Eltoum, I.-E. A., Greenberg, N. M., & Elgavish, A. (2001) · PubMed · Cited by 270
Yang, X., Ferguson, A. T., Nass, S. J., Phillips, D. L., Butash, K. A., Wang, S. M., Herman, J. G., & Davidson, N. E. (2000) · PubMed · Cited by 268
Roodi, N., Bailey, L. R., Kao, W.-Y., Verrier, C. S., Yee, C. J., Dupont, W. D., & Parl, F. F. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.6.446 · Cited by 266
Green, J. E., Shibata, M.-A., Yoshidome, K., Liu, M.-L., Jorcyk, C., Anver, M. R., Wigginton, J., Wiltrout, R., Shibata, E., Kaczmarczyk, S., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203280 · Cited by 260 · cited 2×
“The C3(1)-SV40 Tag transgenic mouse model [FVB-Tg(C3-1-TAg)cJeg/JegJ] was used for prevention model since they can spontaneously develop breast tumors at early ages (around 15–20 wks) [35].”
MethodMajid, S., Kikuno, N., Nelles, J., Noonan, E., Tanaka, Y., Kawamoto, K., Hirata, H., Li, L. C., Zhao, H., Okino, S. T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2290 · Cited by 209 · cited 2×
“One potential mechanism that has recently received considerable attention is that GE may regulate gene transcription by modulating epigenetic events [25-27].”
BackgroundResultMapping of ER gene CpG island methylation-specific polymerase chain reaction.
Lapidus, R. G., Nass, S. J., Butash, K. A., Parl, F. F., Weitzman, S. A., Graff, J. R., Herman, J. G., & Davidson, N. E. (1998) · PubMed · Cited by 206
Genistein Alters Methylation Patterns in Mice
Day, J. K., Bauer, A. M., desBordes, C., Zhuang, Y., Kim, B.-E., Newton, L. G., Nehra, V., Forsee, K. M., MacDonald, R. S., Besch-Williford, C., et al. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2419s · Cited by 203 · cited 1×
“One potential mechanism that has recently received considerable attention is that GE may regulate gene transcription by modulating epigenetic events [25-27].”
BackgroundAdvances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
Shao, W., & Brown, M. (2003) · Breast Cancer Research · doi:10.1186/bcr742 · Cited by 203 · cited 2×
“Several clinical trials have suggested that estrogen ablation or anti-estrogen strategy is effective in the prevention or treatment of breast cancer, especially in estrogen receptors (ERs)-dependent breast cancer [1-3].”
BackgroundTamoxifen treatment and gynecologic side effects: a review
MOURITS, M. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01196-0 · Cited by 200
Li, Y., Yuan, Y.-Y., Meeran, S. M., & Tollefsbol, T. O. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-274 · Cited by 199 · cited 6×
“The activities of HDACs (Active Motif, Carlsbad, CA) and DNMTs (Epigentek, Brooklyn, NY, USA) were performed according to the manufacturer’s protocols as reported previously [32,36].”
BackgroundMethodInfluentialSelf-citationGenistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms
Li, Y., Liu, L., Andrews, L. G., & Tollefsbol, T. O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24398 · Cited by 194 · cited 2×
“ChIP assays were performed with the EZ Chromatin Immunoprecipitation (EZ ChIP) assay kit according to the manufacturer’s protocol (Upstate Biotechnology) as described previously [29,32].”
MethodResultSelf-citationDietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate
Fritz, W. A., Wang, J., Eltoum, I.-E., & Lamartiniere, C. A. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00663-3 · Cited by 169
Chapter 8: Estrogen Receptor-Mediated Processes in Normal and Cancer Cells
Dickson, R. B., & Stancel, G. M. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024237 · Cited by 168 · cited 1×
“However, aberrant activation of estrogen-ER signaling renders unlimited and uncontrolled cell proliferation which occurs in most breast tumors [5-7].”
BackgroundJang, E. R., Lim, S.-J., Lee, E. S., Jeong, G., Kim, T.-Y., Bang, Y.-J., & Lee, J.-S. (2004) · Oncogene · doi:10.1038/sj.onc.1207315 · Cited by 162
Macaluso, M., Cinti, C., Russo, G. M., Russo, A. D., & Giordano, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206578 · Cited by 150
Belguise, K., Guo, S., & Sonenshein, G. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4327 · Cited by 147 · cited 1×
“The bioactive dietary component, for instance, green tea EGCG {(−)-epigallocatechin-3-gallate}, has been shown to activate ER expression via epigenetic control in vitro [32,41].”
BackgroundMeeran, S. M., Patel, S. N., Chan, T.-H., & Tollefsbol, T. O. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0009 · Cited by 146
Self-citationBovenzi, V., & Momparler, R. L. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100294 · Cited by 134 · cited 1×
“Supportive evidence has included intervention application of epigenetic modulators such as DNA methyltranferase (DNMT) inhibitor, 5-aza-2’-deoxycytidine (5-aza), and histone deacetylase (HDAC) inhibitor, trichostatin A (TSA), which successfully induced ER expression and sensitized hormone-resistant ERα-negative breast…”
BackgroundMai, Z., Blackburn, G. L., & Zhou, J. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20300 · Cited by 111
The international variation in breast cancer rates: An epidemiological assessment
Henderson, B. E., & Bernstein, L. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf02633520 · Cited by 111 · cited 2×
“Asian women who consume soybean food as their primary daily diet show low incidence of breast cancer suggesting protective effects of this diet [18,19,38].”
BackgroundTryndyak, V. P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgl050 · Cited by 84 · cited 17×
“(E) Binding abilities of HDACs and DNMTs in the ERα promoter were determined by ChIP assay as described previously.”
BackgroundInfluentialPhyto-oestrogens through the life cycle
Cassidy, A., & Faughnan, M. S. (2000) · Proceedings of The Nutrition Society · doi:10.1017/s0029665100000719 · Cited by 65 · cited 1×
“The concentration of 25 μM GE is equivalent to a maximal daily consumption of soybean product and can also be physiologically attained in blood serum when administrated with a pharmaceutically-available genistein tablet [40], which suggests that this concentration has good bioavailability that could potentially apply…”
BackgroundMai, Z., Blackburn, G. L., & Zhou, J.-R. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm004 · Cited by 64
Gadducci, A., Biglia, N., Sismondi, P., & Genazzani, A. R. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500128492 · Cited by 58 · cited 1×
“However, ERα-negative breast cancers do not respond to TAM treatment and generally have a more clinically aggressive progression resulting in a poorer prognosis [9].”
BackgroundAvailable, N. A. N. (2004) · The Women s Oncology Review · doi:10.1080/14733400412331313133 · Cited by 50
Olaharski, A. J., Ji, Z., Woo, J.-Y., Lim, S., Hubbard, A. E., Zhang, L., & Smith, M. T. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl068 · Cited by 49
The Role of Estrogen and Estrogen Receptors in Chemoresistance
Sui, M., Zhang, H., & Fan, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797379348 · Cited by 36
Cited by
Healthy Effects of Plant Polyphenols: Molecular Mechanisms
Leri, M., Scuto, M., Ontario, M. L., Calabrese, V., Calabrese, E. J., Bucciantini, M., & Stefani, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041250 · Cited by 435
Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances
Tuli, H. S., Tuorkey, M. J., Thakral, F., Sak, K., Kumar, M., Sharma, A. K., Sharma, U., Jain, A., Aggarwal, V., & Bishayee, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01336 · Cited by 387
The role of oxidative stress on breast cancer development and therapy
Hecht, F., Pessoa, C. F., Gentile, L. B., Rosenthal, D., Carvalho, D. P., & Fortunato, R. S. (2016) · Tumor Biology · doi:10.1007/s13277-016-4873-9 · Cited by 303
Botanicals and Their Bioactive Phytochemicals for Women’s Health
Dietz, B. M., Hajirahimkhan, A., Dunlap, T. L., & Bolton, J. L. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.010843 · Cited by 222
“Also, genistein, has been reported to reactivate ERa expression and resensitize ERa-dependent cellular responses to E2 in ERa-negative breast cancer cells, MDA-MB 231, in the micromolar range through epigenetic effects (Li et al., 2013c).”
BackgroundChen, X.-S., Wang, K.-S., Guo, W., Li, L.-Y., Yu, P., Sun, X.-Y., Wang, H.-Y., Guan, Y.-D., Tao, Y.-G., Ding, B.-N., et al. (2020) · Theranostics · doi:10.7150/thno.39814 · Cited by 58
Metadata
- Authors
- Li, Y., Meeran, S. M., Patel, S. N., Chen, H., Hardy, T. M., & Tollefsbol, T. O.
- Venue
- Molecular Cancer
- Published
- 2013
- Volume
- 12
- Issue
- 1
- Pages
- 9
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W2148693352
- Cited by
- 194
- References
- 44
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.